Michael Barbella, Managing Editor06.10.24
KARL STORZ United States has negotiated an exclusive agreement with Well Lead Medical to offer the ClearPetra suction-evacuation ureteral access sheath in conjunction with KARL STORZ endoscopic visualization devices for urinary stone management.
“Our strategic collaboration with Well Lead Medical on ClearPetra represents a major step forward in stone management. We are excited to provide this clinically differentiated technology, which is complementary to the range of solutions KARL STORZ offers urologists,” said Michael Hendershot, vice president of Urology and Gynecology, Sales and Marketing at KARL STORZ United States.
The ClearPetra ureteral access sheath uses negative-pressure aspiration to provide continuous-flow lithotripsy for stone removal.1 Now with a flexible tip, the sheath can be steered into the calyces within the kidney to remove renal stones.
ClearPetra is considered by KARL STORZ a breakthrough in urolithiasis treatment. This strategic collaboration aims to enhance patient care and surgical outcomes.
“The collaboration between Well Lead Medical and KARL STORZ represents a significant milestone in our commitment to advancing endourology. The ClearPetra innovative technology, coupled with KARL STORZ's expertise in endoscopic solutions, will empower urologists to achieve superior surgical outcomes," stated Duan Songfeng, vice general manager of International Sales and Marketing, Research Institute, at Well Lead Medical.
KARL STORZ develops endoscopic technology and surgical imaging solutions across virtually all surgical specialties. The company offers various urology solutions, including numerous approaches to stone management—e.g., flexible ureteroscopy, minimally invasive PCNL, and thulium fiber laser. With global subsidiaries, KARL STORZ is a family-owned company based in Germany that designs, engineers, manufactures, and markets all its products with an emphasis on visionary design, precision craftsmanship, and clinical effectiveness.
References
1 Tuoheti KB et al. A novel double-sheath negative-pressure versus conventional minimally invasive percutaneous nephrolithotomy for large kidney stone. Nature: Sci Rep 13. 2023. doi: 10.1038/s41598-023-50237-7
“Our strategic collaboration with Well Lead Medical on ClearPetra represents a major step forward in stone management. We are excited to provide this clinically differentiated technology, which is complementary to the range of solutions KARL STORZ offers urologists,” said Michael Hendershot, vice president of Urology and Gynecology, Sales and Marketing at KARL STORZ United States.
The ClearPetra ureteral access sheath uses negative-pressure aspiration to provide continuous-flow lithotripsy for stone removal.1 Now with a flexible tip, the sheath can be steered into the calyces within the kidney to remove renal stones.
ClearPetra is considered by KARL STORZ a breakthrough in urolithiasis treatment. This strategic collaboration aims to enhance patient care and surgical outcomes.
“The collaboration between Well Lead Medical and KARL STORZ represents a significant milestone in our commitment to advancing endourology. The ClearPetra innovative technology, coupled with KARL STORZ's expertise in endoscopic solutions, will empower urologists to achieve superior surgical outcomes," stated Duan Songfeng, vice general manager of International Sales and Marketing, Research Institute, at Well Lead Medical.
KARL STORZ develops endoscopic technology and surgical imaging solutions across virtually all surgical specialties. The company offers various urology solutions, including numerous approaches to stone management—e.g., flexible ureteroscopy, minimally invasive PCNL, and thulium fiber laser. With global subsidiaries, KARL STORZ is a family-owned company based in Germany that designs, engineers, manufactures, and markets all its products with an emphasis on visionary design, precision craftsmanship, and clinical effectiveness.
References
1 Tuoheti KB et al. A novel double-sheath negative-pressure versus conventional minimally invasive percutaneous nephrolithotomy for large kidney stone. Nature: Sci Rep 13. 2023. doi: 10.1038/s41598-023-50237-7